Paul Tabereaux
Overview
Explore the profile of Paul Tabereaux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
17
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gill J, Crossen K, Blauth C, Kerendi F, Oza S, Magnano A, et al.
Ann Cardiothorac Surg
. 2024 Apr;
13(2):155-164.
PMID: 38590997
Background: CONVERGE was a prospective, multicenter, randomized controlled trial that evaluated the safety of Hybrid Atrial Fibrillation Convergent (HC) and compared its effectiveness to endocardial catheter ablation (CA) for the...
2.
DeLurgio D, Blauth C, Halkos M, Crossen K, Talton D, Oza S, et al.
Heart Rhythm O2
. 2023 Mar;
4(2):111-118.
PMID: 36873309
Background: Favorable clinical outcomes are difficult to achieve in long-standing persistent atrial fibrillation (LSPAF) with catheter ablation (CA). The CONVERGE (Convergence of Epicardial and Endocardial Ablation for the Treatment of...
3.
Di Biase L, Tabereaux P, Liu C, Vasaiwala S, Chugh A, Saliba W
Circ Arrhythm Electrophysiol
. 2022 Nov;
15(12):e011561.
PMID: 36445824
No abstract available.
4.
Di Biase L, Monir G, Melby D, Tabereaux P, Natale A, Manyam H, et al.
JACC Clin Electrophysiol
. 2022 Sep;
8(9):1077-1089.
PMID: 36137711
Background: VISITAG SURPOINT (VS)-guided ablation of paroxysmal atrial fibrillation has demonstrated good short- and long-term success rates with low rates of complications in recent, predominantly European, studies. However, there is...